Synthesis, antiviral activity and molecular modeling of oxoquinoline derivatives

Bioorg Med Chem. 2009 Aug 1;17(15):5476-81. doi: 10.1016/j.bmc.2009.06.037. Epub 2009 Jun 24.

Abstract

In the present article, we describe the synthesis, anti-HIV1 profile and molecular modeling evaluation of 11 oxoquinoline derivatives. The structure-activity relationship analysis revealed some stereoelectronic properties such as LUMO energy, dipole moment, number of rotatable bonds, and of hydrogen bond donors and acceptors correlated with the potency of compounds. We also describe the importance of substituents R(2) and R(3) for their biological activity. Compound 2j was identified as a lead compound for future investigation due to its: (i) high activity against HIV-1, (ii) low cytotoxicity in PBMC, (iii) low toxic risks based on in silico evaluation, (iv) a good theoretical oral bioavailability according to Lipinski 'rule of five', (v) higher druglikeness and drug-score values than current antivirals AZT and efavirenz.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-HIV Agents / chemical synthesis*
  • Anti-HIV Agents / chemistry
  • Anti-HIV Agents / pharmacokinetics
  • Anti-HIV Agents / pharmacology*
  • Cell Survival / drug effects
  • Chlorocebus aethiops
  • HIV Infections / drug therapy
  • HIV-1 / drug effects*
  • HIV-1 / growth & development
  • Humans
  • Leukocytes, Mononuclear / cytology
  • Leukocytes, Mononuclear / drug effects
  • Leukocytes, Mononuclear / virology
  • Models, Molecular
  • Molecular Structure
  • Quinolones / chemical synthesis*
  • Quinolones / chemistry
  • Quinolones / pharmacokinetics
  • Quinolones / pharmacology*
  • Structure-Activity Relationship
  • Vero Cells

Substances

  • Anti-HIV Agents
  • Quinolones